Taylor Wealth Management Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-650
Closed -$40K 136
2017
Q4
$40K Hold
650
0.02% 100
2017
Q3
$41K Hold
650
0.02% 102
2017
Q2
$36K Sell
650
-425
-40% -$23.1K 0.02% 106
2017
Q1
$58K Sell
1,075
-300
-22% -$16.5K 0.03% 99
2016
Q4
$80K Sell
1,375
-875
-39% -$47.8K 0.04% 89
2016
Q3
$121K Sell
2,250
-100
-4% -$6.42K 0.05% 65
2016
Q2
$173K Hold
2,350
0.07% 50
2016
Q1
$150K Buy
2,350
+600
+34% +$37.8K 0.07% 47
2015
Q4
$120K Hold
1,750
0.05% 56
2015
Q3
$104K Sell
1,750
-100
-5% -$6.34K 0.05% 55
2015
Q2
$123K Buy
1,850
+1,450
+363% +$95.6K 0.04% 57
2015
Q1
$26K Buy
+400
New +$25K 0.01% 101

Other funds holding BMY

Taylor Wealth Management Partners's BMY Position: Q1 2018 in Review

Taylor Wealth Management Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 650 shares — an estimated $40K sold.

Taylor Wealth Management Partners first reported a position in BMY in Q1 2015 and held it in 12 quarters. The position peaked at $173K in Q2 2016. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • Taylor Wealth Management Partners reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
  • Taylor Wealth Management Partners sold 650 Bristol-Myers Squibb shares in Q1 2018, an estimated $40K.
  • Taylor Wealth Management Partners first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 12 quarters.
  • Taylor Wealth Management Partners's Bristol-Myers Squibb position peaked at $173K in Q2 2016.
  • 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Taylor Wealth Management Partners's 13F filing for Q1 2018, filed 11 Apr 2018.